Wilma Bergman
Professor emeritus
- Name
- Prof. dr. W. Bergman
- Telephone
- 071 5262497
- w.bergman@lumc.nl
- ORCID iD
- 0000-0002-6367-3830
Professor emeritus
- LUMC
Contact
- Davies, J.R.; Chang, Y.M.; Bishop, D.T.; Armstrong, B.K.; Bataille, V.; Bergman, W.; Berwick, M.; Bracci, P.M.; Elwood, J.M.; Ernstoff, M.S.; Green, A.; Gruis, N.A.; Holly, E.A.; Ingvar, C.; Kanetsky, P.A.; Karagas, M.R.; Lee, T.K.; Marchand, L. le; Mackie, R.M.; Olsson, H.; Osterlind, A.; Rebbeck, T.R.; Reich, K.; Sasieni, P.; Siskind, V.; Swerdlow, A.J.; Titus, L.; Zens, M.S.; Ziegler, A.; Gallagher, R.P.; Barrett, J.H. & Newton-Bishop, J. (2015), Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case-Control Studies, Cancer Epidemiology, Biomarkers and Prevention 24(5): 817-824.
- Potjer, T.P.; Kranenburg, H.E.; Bergman, W.; Cappel, W.H.D.T.N.; Monsjou, H.S. van; Barge-Schaapveld, D.Q.C.M. & Vasen, H.F.A. (2015), Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant, European Journal of Human Genetics 23(5): 711-714.
- Wevers, K.P.; Hoekstra-Weebers, J.E.H.M.; Speijers, M.J.; Bergman, W.; Gruis, N.A. & Hoekstra, H.J. (2014), Cutaneous melanoma: Medical specialists' opinions on follow-up and sentinel lymph node biopsy, EJSO - European Journal of Surgical Oncology 40(10): 1276-1283.
- Rhee, J.I. van der; Boonk, S.E.; Putter, H.; Cannegieter, S.C.; Flinterman, L.E.; Hes, F.J.; Snoo, F.A. de; Mooi, W.J.; Gruis, N.A.; Vasen, H.F.A.; Kukutsch, N.A. & Bergman, W. (2013), Surveillance of Second-Degree Relatives from Melanoma Families with a CDKN2A Germline Mutation, Cancer Epidemiology, Biomarkers and Prevention 22(10): 1771-1777.
- Iles, M.M.; Law, M.H.; Stacey, S.N.; Han, J.L.; Fang, S.Y.; Pfeiffer, R.; Harland, M.; MacGregor, S.; Taylor, J.C.; Aben, K.K.; Akslen, L.A.; Avril, M.F.; Azizi, E.; Bakker, B.; Benediktsdottir, K.R.; Bergman, W.; Scarra, G.B.; Brown, K.M.; Calista, D.; Chaudru, V.; Fargnoli, M.C.; Cust, A.E.; Demenais, F.; Waal, A.C. de; Debniak, T.; Elder, D.E.; Friedman, E.; Galan, P.; Ghiorzo, P.; Gillanders, E.M.; Goldstein, A.M.; Gruis, N.A.; Hansson, J.; Helsing, P.; Hocevar, M.; Hoiom, V.; Hopper, J.L.; Ingvar, C.; Janssen, M.; Jenkins, M.A.; Kanetsky, P.A.; Kiemeney, L.A.; Lang, J.L.; Lathrop, G.M.; Leachman, S.; Lee, J.E.; Lubinski, J.; Mackie, R.M.; Mann, G.J.; Martin, N.G.; Mayordomo, J.I.; Molven, A.; Mulder, S.; Nagore, E.; Novakovic, S.; Okamoto, I.; Olafsson, J.H.; Olsson, H.; Pehamberger, H.; Peris, K.; Grasa, M.P.; Planelles, D.; Puig, S.; Puig-Butille, J.A.; Randerson-Moor, J.; Requena, C.; Rivoltini, L.; Rodolfo, M.; Santinami, M.; Sigurgeirsson, B.; Snowden, H.; Song, F.J.; Sulem, P.; Thorisdottir, K.; Tuominen, R.; Belle, P. van; Stoep, N. van der; Rossum, M.M. van; Wei, Q.Y.; Wendt, J.; Zelenika, D.; Zhang, M.F.; Landi, M.T.; Thorleifsson, G.; Bishop, D.T.; Amos, C.I.; Hayward, N.K.; Stefansson, K.; Bishop, J.A.N.; Barrett, J.H.; Q-MEGA AMFS Investigators & GenoMEL Consortium (2013), A variant in FTO shows association with melanoma risk not due to BMI, Nature Genetics 45(4): 428-432.
- Kasparian, N.A.; Branstrom, R.; Chang, Y.M.; Affleck, P.; Aspinwall, L.G.; Tibben, A.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N.K.; Hocevar, M.; Kanetsky, P.A.; Leachman, S.; Bergman, W.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, D.; Grius, N.A.; Newton-Bishop, J.; Brandberg, Y. & Melanoma Genetics Consortium GenoM (2012), Skin Examination Behavior The Role of Melanoma History, Skin Type, Psychosocial Factors, and Region of Residence in Determining Clinical and Self-conducted Skin Examination, Archives of Dermatology -Chicago- 148(10): 1142-1151.
- Gao, L.; Nieuwpoort, F.A. van; Out, J.J.; Hensbergen, P.J.; Snoo, F.A. de; Bergman, W.; Doorn, R. van & Gruis, N.A. (2012), Genome-wide analysis of gene and protein expression of dysplastic naevus cells., Journal of Skin Cancer 2012: 981308.
- Argenziano, G.; Zalaudek, I.; Hofmann-Wellenhof, R.; Bakos, R.M.; Bergman, W.; Blum, A.; Broganelli, P.; Cabo, H.; Caltagirone, F.; Catricala, C.; Coppini, M.; Dewes, L.; Francia, M.G.; Garrone, A.; Turk, B.G.; Ghigliotti, G.; Giacomel, J.; Gourhant, J.Y.; Hlavin, G.; Kukutsch, N.; Lipari, D.; Melchionda, G.; Ozdemir, F.; Pellacani, G.; Pellicano, R.; Puig, S.; Scalvenzi, M.; Sortino-Rachou, A.M.; Virgili, A.R. & Kittler, H. (2012), Total body skin examination for skin cancer screening in patients with focused symptoms, Journal of The American Academy of Dermatology 66(2): 212-219.
- Bergman, W. & Meijling, K.G. (2012), Commentary II: The Void of Congenital Naevi, Acta Dermato-Venereologica 92(6): 586-586.
- Branstrom, R.; Kasparian, N.A.; Affleck, P.; Tibben, A.; Chang, Y.M.; Azizi, E.; Baron-Epel, O.; Bergman, W.; Chan, M.; Davies, J.; Ingvar, C.; Kanetsky, P.A.; Leeuwen, E. van; Olsson, H.; Gruis, N.A.; Brandberg, Y. & Newton-Bishop, J. (2012), Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma, European Journal of Cancer 48(16): 3052-3062.
- Quint, K.D.; Rhee, J.I. van der; Gruis, N.A.; Huurne, J.A. ter; Wolterbeek, R.; Stoep, N. van der; Bergman, W. & Kukutsch, N.A. (2012), Melanocortin 1 Receptor (MC1R) Variants in High Melanoma Risk Patients are Associated with Specific Dermoscopic ABCD Features, Acta Dermato-Venereologica 92(6): 587-592.
- Barrett, J.H.; Iles, M.M.; Harland, M.; Taylor, J.C.; Aitken, J.F.; Andresen, P.A.; Akslen, L.A.; Armstrong, B.K.; Avril, M.F.; Azizi, E.; Bakker, B.; Bergman, W.; Bianchi-Scarra, G.; Bressac-de Paillerets, B.; Calista, D.; Cannon-Albright, L.A.; Corda, E.; Cust, A.E.; Debniak, T.; Duffy, D.; Dunning, A.M.; Easton, D.F.; Friedman, E.; Galan, P.; Ghiorzo, P.; Giles, G.G.; Hansson, J.; Hocevar, M.; Hoiom, V.; Hopper, J.L.; Ingvar, C.; Janssen, B.; Jenkins, M.A.; Jonsson, G.; Kefford, R.F.; Landi, G.; Landi, M.T.; Lang, J.; Lubinski, J.; Mackie, R.; Malvehy, J.; Martin, N.G.; Molven, A.; Montgomery, G.W.; Nieuwpoort, F.A. van; Novakovic, S.; Olsson, H.; Pastorino, L.; Puig, S.; Puig-Butille, J.A.; Randerson-Moor, J.; Snowden, H.; Tuominen, R.; VanBelle, P.; Stoep, N. van der; Whiteman, D.C.; Zelenika, D.; Han, J.L.; Fang, S.Y.; Lee, J.E.; Wei, Q.Y.; Lathrop, G.M.; Gillanders, E.M.; Brown, K.M.; Goldstein, A.M.; Kanetsky, P.A.; Mann, G.J.; MacGregor, S.; Elder, D.E.; Amos, C.I.; Hayward, N.K.; Gruis, N.A.; Demenais, F.; Bishop, J.A.N.; Bishop, D.T. & GenoMEL Consortium (2011), Genome-wide association study identifies three new melanoma susceptibility loci, Nature Genetics 43(11): 1108-U98.
- Rhee, J.I. van der; Bergman, W. & Kukutsch, N.A. (2011), Impact of Dermoscopy on the Management of High-risk Patients From Melanoma Families: A Prospective Study, Acta Dermato-Venereologica 91(4): 428-431.
- Rhee, J.I. van der; Snoo, F.A. de; Vasen, H.F.A.; Mooi, W.J.; Putter, H.; Gruis, N.A.; Kukutsch, N.A. & Bergman, W. (2011), Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families, Journal of The American Academy of Dermatology 65(2): 289-296.
- Rhee, J.I. van der; Krijnen, P.; Gruis, N.A.; Snoo, F.A. de; Vasen, H.F.A.; Putter, H.; Kukutsch, N.A. & Bergman, W. (2011), Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A, Journal of The American Academy of Dermatology 65(2): 281-288.
- Lang, J.M.; Shennan, M.; Njauw, J.C.N.; Luo, S.; Bishop, J.N.; Harland, M.; Hayward, N.K.; Tucker, M.A.; Goldstein, A.M.; Landi, M.T.; Puig, S.; Gruis, N.A.; Bergman, W.; Bianchi-Scarra, G.; Ghiorzo, P.; Hogg, D. & Tsao, H. (2011), A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds, Journal of Investigative Dermatology 131(2): 480-486.
- Vasen, H.F.A.; Wasser, M.; Mil, A. van; Tollenaar, R.A.; Konstantinovski, M.; Gruis, N.A.; Bergman, W.; Hes, F.J.; Hommes, D.W.; Offerhaus, G.J.A.; Morreau, H.; Bonsing, B.A. & Cappel, W.H.D.T.N. (2011), Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation, Gastroenterology 140(3): 850-856.
- Rhee, J.I. van der; Mooi, W.J.; Kukutsch, N.A.; Snoo, F.A. de & Bergman, W. (2010), Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?, British Journal of Dermatology 162(2): 457-458.
- Veerbeek L, van de Poll-Franse LV, Bekkenk MW, Bergman W, Hoekstra HJ, Jansen-Landheer ML, Kruit WH, Mooi WJ, de Vries E & van der Rhee HJ (2010), [Improved compliance with the 'Melanoma' treatment guideline].
- Quint KD, van der Helm-van Mil AH, Bergman W & Lavrijsen AP (2010), [Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis].
- Demenais, F.; Mohamdi, H.; Chaudru, V.; Goldstein, A.M.; Bishop, J.A.N.; Bishop, D.T.; Kanetsky, P.A.; Hayward, N.K.; Gillanders, E.; Elder, D.E.; Avril, M.F.; Azizi, E.; Belle, P. van; Bergman, W.; Bianchi-Scarra, G.; Bressac-de Paillerets, B.; Calista, D.; Carrera, C.; Hansson, J.; Harland, M.; Hogg, D.; Hoiom, V.; Holland, E.A.; Ingvar, C.; Landi, M.T.; Lang, J.M.; Mackie, R.M.; Mann, G.J.; Ming, M.E.; Njauw, C.J.; Olsson, H.; Palmer, J.; Pastorino, L.; Puig, S.; Randerson-Moor, J.; Stark, M.; Tsao, H.; Tucker, M.A.; Velden, P. van der; Yang, X.R.; Gruis, N. & Melanoma Genetics Consortium (2010), Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study, JNCI: Journal of the National Cancer Institute 102(20): 1568-1583.
- Branstrom, R.; Kasparian, N.A.; Chang, Y.M.; Affleck, P.; Tibben, A.; Aspinwall, L.G.; Azizi, E.; Baron-Epel, O.; Battistuzzi, L.; Bergman, W.; Bruno, W.; Chan, M.; Cuellar, F.; Debniak, T.; Pjanova, D.; Ertmanski, S.; Figl, A.; Gonzalez, M.; Hayward, N.K.; Hocevar, M.; Kanetsky, P.A.; Leachman, S.A.; Heisele, O.; Palmer, J.; Peric, B.; Puig, S.; Schadendorf, D.; Gruis, N.A.; Newton-Bishop, J. & Brandberg, Y. (2010), Predictors of Sun Protection Behaviors and Severe Sunburn in an International Online Study, Cancer Epidemiology, Biomarkers and Prevention 19(9): 2199-2210.
- Rhee, J.I. van der; Bergman, W. & Kukutsch, N.A. (2010), The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study, British Journal of Dermatology 162(3): 563-567.
- Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJF, Manning AK, Jackson AU & Aulchenko Y (2009), Variants in MTNR1B influence fasting glucose levels, Nature Genetics 41(1): 77-81.
- Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarra G, Brentnall T, Bressac-de Paillerets B & Bruno W (2009), Selection criteria for genetic assessment of patients with familial melanoma, Journal of The American Academy of Dermatology 61(4): 677-684.
- Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM & Ernstoff MS (2009), Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls, International Journal of Epidemiology 38(3): 814-830.
- Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM & Ernstoff MS (2009), A pooled analysis of Melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes, International Journal of Cancer 124(2): 420-428.
- de Snoo FA, Hottenga JJ, Gillanders EM, Sandkuijl LA, Jones MP, Bergman W, van der Drift C, van Leeuwen I, van Mourik L, ter Huurne JAC, Frants RR, Willemze R, Breuning MH, Trent JM & Gruis NA (2008), Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families, European Journal of Human Genetics 16(9).
- de Snoo FA, Bishop DT, Bergman W, van Leeuwen I, van der Drift C, van Nieuwpoort FA, Out-Luiting CJ, Vasen HF, ter Huurne JAC, Frants RR, Willemze R, Breuning MH & Gruis NA (2008), Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families, Clinical Cancer Research 14(21).
- Van Nieuwpoort AF, Out C, Weerheim A, Pavel S, Bergman W & Gruis N (2008), Gene expression and protein profiling of normal and atypical melanocytes, Pigment Cell and Melanoma Research 21(2).
- de Snoo FA, Rledijk SR, van Mil AM, Bergman W, ter Huurne JAC, Timman R, Bertina W, Gruis NA, Vasen HFA, van Haeringen A, Breuning MH & Tibben A (2008), Genetic testing in familial melanoma: uptake and implications, Psycho-Oncology 17(8).
- Harland M, Goldstein AM, Kukalizch K, Taylor C, Hogg D, Puig S, Badenas C, Gruis N, ter Huurne J, Bergman W, Hayward NK, Stark M, Tsao H, Tucker MA, Landi MT, Scarra GB, Ghiorzo P, Kanetsky PA, Elder D, Mann GJ, Holland EA, Bishop DT & Bishop JN (2008), A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL), European Journal of Cancer 44(9).
- Koomen E.R., Joosse A., Herings R.M.C., Casparie M.K., Bergman W., Nijsten T. & Guchelaar H.-J. (2007), Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?, European Journal of Cancer 43(17): 2580-2589.
- de Snoo FA, Kroon MW, Bergman W, ter Huurne JAC, Houwing-Duistermaat JJ, van Mourik L, Snels DGCTM, Breuning MH, Willemze R, Frants RR & Gruis NA (2007), From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients, Journal of The American Academy of Dermatology 56(5).
- Bergman W (2007), Phenotypic variation in familial melanoma: a handicap for offering DNA diagnosis to families, EJC Supplements 5(4).
- Bergman W & Gruis NA (2007), Phenotypic variation in familial melanoma - Consequences for predictive DNA testing, Archives of Dermatology -Chicago- 143(4).
- Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LAC, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L & Yakobson E (2007), Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents, Journal of Medical Genetics 44(2).
- Koomen ER, Joosse A, Herings RMC, Casparie MK, Bergman W, Nijstene T & Guchelaar HJ (2007), Is station use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?, European Journal of Cancer 43(17).
- Riedijk SR, De Snoo FA, Van Dijk S, Bergman W, Van Haeringen A, Silberg S, Van Elderen TMT & Tibben A (2005), Hereditary melanoma and predictive genetic testing: Why not?, Psycho-Oncology 14(9).
- Hayes MJ, Koundouris A, Gruis N, Bergman W, Peters GG & Sinclair AJ (2004), P16(INK4A)-independence of Epstein-Barr virus-induced cell proliferation and virus latency, Journal of General Virology 85.
- Gillanders E, Juo SHH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop JN, Goldstein AM, Bailey-Wilson JE, Mann GJ, Hayward N & Trent J (2003), Localization of a novel melanoma susceptibility locus to 1p22, American Journal of Human Genetics 73(2).
- Pavel S, Smit NPM, van der Meulen H, Kolb RM, de Groot AJL, van der Velden PA, Gruis NA & Bergman W (2003), Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case, Melanoma Research 13(2).
- Cappel WHDTN, Offerhaus GJA, van Puijenbroek M, Caspers E, Gruis NA, de Snoo FA, Lamers CBHW, Griffioen G, Bergman W, Vasen HFA & Morreau H (2003), Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden), Clinical Cancer Research 9(10).
- Kefford R, Bishop JN, Tucker M, Bressac-de-Paillerets B, Bianchi-Scarra G, Bergman W, Goldstein A, Puig S, Mackie R, Elder D, Hansson J, Hayward N, Hogg D & Olsson H (2002), Genetic testing for melanoma, Lancet Oncology 3(11).
- Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W & Peters G (2002), INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence, EMBO Journal 21(12).
- Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A & Tucker MA (2002), Geographical variation in the penetrance of CDKN2A mutations for melanoma, JNCI: Journal of the National Cancer Institute 94(12).
- van der Velden PA, Metzelaar-Blok JAW, Bergman W, Hurks HMH, Frants RR, Gruis NA & Jager MJ (2001), Promoter hypermethylation: A common cause of reduced p16(INK4a) expression in uveal melanoma, Cancer Research 61(13).
- Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer BJ & Bavinck JNB (2001), The melanocortin-1-receptor gene is the major freckle gene, Human Molecular Genetics 10(16).
- Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R & Bavinck JNB (2001), Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color, Journal of Investigative Dermatology 117(2).
- van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR & Gruis NA (2001), Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma, American Journal of Human Genetics 69(4).
- Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J & Bergman W (2001), Multiple primary melanomas, Journal of The American Academy of Dermatology 44(1).
- Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM & Bergman W (2000), Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
- Hulshof MM, Bavinck JNB, Bergman W, Masclee AAM, Heickendorff L, Breedveld FC & Dijkmans BAC (2000), Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma, Journal of The American Academy of Dermatology 43(6).
- Bishop JAN, Bradburn M, Bergman W, Osterlind A, Pinney E, Rosdahl I, Scerri L, Weichenthal M, Mant D, Breitbart EW, Karlsson P & Altman DG (2000), Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study.
- Ak I, Stokkel MPM, Bergman W & Pauwels EKJ (2000), Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment.
- Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ & Rooijmans HGM (2000), Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up.
- van der Linden MW, Westendorp RGJ, Sturk A, Bergman W & Huizinga TWJ (2000), High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.
- Gruis NA, van der Velden PA, Bergman W & Frants RR (1999), Familial melanoma; CDKN2A and beyond.
- Gruis NA, Van der Velden PA, Bergman W & Frants RR (1998), Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in the Netherlands: how far have we come?, Bulletin du Cancer 85(7): 627-630.